Nutriband Inc. (NTRB) is a Biotechnology company in the Healthcare sector, currently trading at $4.06. It has a SharesGrow Score of 50/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Valuation: NTRB trades at a trailing Price-to-Earnings (P/E) of -3.8 (S&P 500 average ~25).
Financials: revenue is $2M, +16.4%/yr average growth. Net income is $10M (loss), growing at -20.8%/yr. Net profit margin is -489.9% (negative). Gross margin is 32.7% (-2.8 pp trend).
Balance sheet: total debt is $186,349 against $6M equity (Debt-to-Equity (D/E) ratio 0.03, conservative). Current ratio is 4.88 (strong liquidity). Debt-to-assets is 2.5%. Total assets: $7M.
Analyst outlook: 1 / 1 analysts rate NTRB as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 48/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 27/100 (Fail), Future 100/100 (Pass), Income 10/100 (Fail).
